Chendu DIAO Pharmaceutical Group CO., LTD.
6 clinical trials · Sponsor
◉ Watch Chendu DIAO Pharmaceutical Group CO., LTD.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes (NCT07755150) | Chendu DIAO Pharmaceutical Group CO., LTD. | 2026-08-30 |
| A Study of DA-302168S in Participants With Overweight/Obesity (NCT07629544) | Chendu DIAO Pharmaceutical Group CO., LTD. | 2026-06-19 |
| A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Overweight/Obese Subjects (NCT06953063) | Chendu DIAO Pharmaceutical Group CO., LTD. | 2025-05-15 |
| A Study Evulating DA-302168S Tablets in Overweight/Obese Subjects (NCT06541730) | Chendu DIAO Pharmaceutical Group CO., LTD. | 2024-08-30 |
| The Food Effect on Pharmacokinetics of DA-302168S (NCT06534346) | Chendu DIAO Pharmaceutical Group CO., LTD. | 2024-07-18 |
| Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of DA-302168S Tablets (NCT06534320) | Chendu DIAO Pharmaceutical Group CO., LTD. | 2024-04-18 |
Track Chendu DIAO Pharmaceutical Group CO., LTD. automatically
Every clearance here is in the API, with alerts when new ones post.